Real-life utilization of BioFire^® Filmarray^® pneumonia panel as an antibiotic stewardship tool

Daisuke Furukawa^{1

2}, Brian Kim^{3

4}, Arthur Jeng^{1

4}

Affiliations

¹ David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
² Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, CA, USA.
³ Department of Pharmacy, Olive View-UCLA Medical Center, Sylmar, CA, USA.
⁴ Department of Medicine, Division of Infectious Diseases, Olive View-UCLA Medical Center, Sylmar, CA, USA.

Comment

Daisuke Furukawa et al. Infect Dis (Lond). 2021 Apr.

. 2021 Apr;53(4):308-313.

doi: 10.1080/23744235.2020.1866774. Epub 2020 Dec 30.

Daisuke Furukawa^{1

2}, Brian Kim^{3

4}, Arthur Jeng^{1

4}

¹ David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
² Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles, CA, USA.
³ Department of Pharmacy, Olive View-UCLA Medical Center, Sylmar, CA, USA.
⁴ Department of Medicine, Division of Infectious Diseases, Olive View-UCLA Medical Center, Sylmar, CA, USA.

No abstract available

Comment on

Evaluation of the Biofire Filmarray Pneumonia panel plus for lower respiratory tract infections.
Edin A, Eilers H, Allard A. Edin A, et al. Infect Dis (Lond). 2020 Jul;52(7):479-488. doi: 10.1080/23744235.2020.1755053. Epub 2020 Apr 22. Infect Dis (Lond). 2020. PMID: 32319831